GEN DIGITAL INC (GEN)
(Delayed Data from NSDQ)
$26.48 USD
-0.39 (-1.45%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $26.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$26.48 USD
-0.39 (-1.45%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $26.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Zacks News
Gen Digital (GEN) Beats on Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Gen Digital's (GEN) Q4 results reflect strong customer growth and the benefits of the global business expansion and the Avast acquisition, leading to year-over-year growth in revenues and bookings.
Gen Digital (GEN) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Gen Digital (GEN) delivered earnings and revenue surprises of 6.98% and 1.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Genpact (G) Beats Q1 Earnings Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of 4.62% and 0.64%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Gen Digital (GEN) in Q4 Earnings?
by Zacks Equity Research
Post the acquisition, the integration of Avast Plc is likely to have driven Gen Digital's (GEN) Q4 top line. However, the equity dilution impact of the same acquisition is anticipated to have weighed on the EPS.
Gen Digital (GEN) Tops on Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Gen Digital's (GEN) Q3 results reflect strong customer growth and the benefits of the global business expansion and the Avast acquisition, leading to year-over-year growth in revenues and bookings.
Gen Digital (GEN) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Gen Digital (GEN) delivered earnings and revenue surprises of 7.14% and 0.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Gen Digital (GEN) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Gen Digital's (GEN) Q3 top line is likely to have benefited from the inclusion of the Avast business. However, the equity dilution impact of the Avast acquisition is anticipated to have weighed on EPS.
Do Options Traders Know Something About Gen Digital (GEN) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Gen Digital (GEN) stock based on the movements in the options market lately.
NortonLifeLock (GEN) Down 1.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
NortonLifeLock (GEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights Gen Digital, ADT and KnowBe4
by Zacks Equity Research
Gen Digital, ADT and KnowBe4 have been highlighted in this Industry Outlook article.
3 Security and Safety Services Stocks to Beat Industry Woes
by Eshani Haque
Supply chain woes and cost inflation weigh on the Zacks Security and Safety Services industry's near-term prospects. However, GEN, ADT and KNBE are set to benefit from continued demand, product upgrades and digitization.
Gen Digital (GEN) Gains on Q2 Earnings Meet, Revenue Beat
by Zacks Equity Research
Gen Digital's (GEN) Q2 results reflect strong customer growth and the benefits of the global business expansion and the Avast acquisition, leading to year-over-year growth in revenues and bookings.
Ensign Group (ENSG) Continues to Gain From Buyout Binge
by Zacks Equity Research
Ensign Group's (ENSG) series of buyouts poise it well for growth by enhancing its capabilities, both financially and clinically.
Genesis Healthcare Enters Oversold Territory
by Zacks Equity Research
Genesis Healthcare has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
HCA Healthcare Plunges Above 39% Year to date: Here's Why
by Zacks Equity Research
HCA Healthcare (HCA) stock plunges due to halt in elective surgeries, exorbitant costs and an escalating leverage level.
Brookdale Scraps Earnings View Due to COVID-19 Uncertainty
by Zacks Equity Research
Brookdale (BKD) pulls down 2020 earnings guidance, takes steps to preserve liquidity and incurs additional cost for prevention measures.
Ensign Group Expands Colorado Presence With Twin Buyouts
by Zacks Equity Research
Ensign Group (ENSG) continues with its buyout binge by acquiring nursing facilities in Colorado.
Ensign Acquires Healthcare Center, Buyout Spree Continues
by Sapna Bagaria
The acquisition of Healthcare Center adds to Ensign Group's (ENSG) portfolio of skilled nursing and independent living services.
Why Should You Retain Molina Healthcare in Your Portfolio?
by Zacks Equity Research
On the back of its restructuring initiatives and solid membership, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
Ensign Group (ENSG) Takes Shareholder-Friendly Initiatives
by Zacks Equity Research
Ensign Group (ENSG) clears a quarterly dividend hike to share more profits with investors.
Tenet Healthcare to Divest Units for Streamlining Operations
by Zacks Equity Research
Tenet Healthcare (THC) to sell its Memphis area units for clearing its debt and focusing on core business.
Tenet Healthcare Soars 117.1% YTD: Will Growth Continue?
by Zacks Equity Research
Tenet Healthcare's (THC) partnerships and acquisitions are likely to continue boosting its revenue base, which in turn, might perk up its share price.
Humana's (HUM) Alliances to Offer Relief to Members With CKD
by Zacks Equity Research
Humana (HUM) collaborates with Monogram Health and Somatus to provide its Humana Medicare Advantage and Commercial members, who are renal patients, with better healthcare in select geographies.
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on a growing top line and higher membership, Anthem (ANTM) holds enough potential to reap benefits for investors.
The Zacks Analyst Blog Highlights: Cross Country Healthcare, Genesis Healthcare, Chuy's, Consulting and Huron Consulting
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cross Country Healthcare, Genesis Healthcare, Chuy's, Consulting and Huron Consulting